we are

Cardiovascular Systems, Inc.

CSI is committed to providing physicians around the world with innovative solutions for the revascularization of patients with complex coronary and peripheral artery disease. Through enhancing current technologies, developing new products, robust medical education, superior clinical evidence, and leveraging industry partnerships, we are broadening our end-to-end cardiovascular intervention solutions to help treat more patients worldwide.

CSI’s Focus During COVID-19

Protecting Our Employees

CSI is taking responsibility to serve physicians and patients in need and we are following the recommendations from the Centers for Disease Control and the World Health Organization, as well as State and Local Hospital requirements to prioritize safety, protect our employees and to best protect healthcare teams who are treating patients around the world. We have provided each of our employees with personal protective equipment (if it is preferred or beneficial for hospitals/clinics to conserve their own supply).

Commitment to Our Customers

CSI remains committed to providing the important medical devices that help our physicians treat challenging patient populations and we stand ready to support you in your general practice and in the care of your more severe cases that cannot be postponed. Our field employees are ready to work with you to identify solutions in case support, whether remotely or in person, given your hospital/clinic needs.

Uninterrupted Supply Chain

Our orbital atherectomy devices are manufactured in the United States at our Minnesota and Texas facilities and production is continuing as usual. In addition, we do not anticipate any disruptions in our supply chain for OrbusNeich distributed products like the Sapphire® angioplasty balloons and Teleport® Microcatheters.

We will continue to monitor developments related to the COVID-19 outbreak and will provide updates if our circumstances change. Should you have any questions, please call 1-877-CSI-0360.


News from CSI

Let us keep you informed of our latest information, evidence and advances in our commercialization of innovative solutions addressing the most compelling unmet medical needs in interventional cardiology.





Patient Stories

Learn more about actual patients who were helped getting back to what matters after being treated with CSI’s orbital atherectomy products.



Improving
Patient
Access

By raising awareness of coronary artery disease (CAD) and peripheral artery disease (PAD) and encouraging screening, CSI is committed to help improve patient outcomes.

Addressing
Racial
Disparities

Research has shown minority populations are at greater risk of amputation with advanced PAD. CSI is working to reduce the gap through education campaigns and patient advocacy.

Delivering
Medical & Economic
Evidence

Addressing calcium in arterial disease has implications for all revascularization procedures. CSI is committed to providing value-based analysis through cost-effective, long-term outcomes.

Collaborating With
Others

CSI is committed to constant innovation and collaborating with physicians and their teams around the globe to surround patients with top quality tools that improve outcomes and manage costs.


400000+
Patients Served
2000+
Healthcare Facilities
700+
CSI Team Members


Contact us for more info


Contact